Levine, Douglas A.
Merck & Co., Inc.,
United States
2025 Rank: 90978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3583 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90978 | 102472 |
| Total Cites | 70738 | 79156 |
| H-index | 103 | 108 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 914 | 947 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 5689 | 6206 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 53325 | 57396 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
10.63%
|
|
Levine, Douglas A.
Merck & Co., Inc.,
United States
2024 Rank: 91510
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3616 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91510 | 99479 |
| Total Cites | 61767 | 69755 |
| H-index | 103 | 107 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 889 | 922 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 5079 | 5572 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 46292 | 50099 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
11.45%
|
|
Levine, Douglas A.
Memorial Sloan-Kettering Cancer Center,
United States
2023 Rank: 91528
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3650 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91528 | 102027 |
| Total Cites | 51371 | 58402 |
| H-index | 96 | 101 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 872 | 905 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 4455 | 4915 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 38579 | 41964 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
12.04%
|
|
Levine, Douglas A.
NYU Langone Health,
United States
2022 Rank: 117972
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4569 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117972 | 129162 |
| Total Cites | 37375 | 42637 |
| H-index | 81 | 86 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 834 | 864 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 3785 | 4198 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 28341 | 31010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
12.34%
|
|
Levine, Douglas A.
NYU Langone Health,
United States
2021 Rank: 117679
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4591 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117679 | 128111 |
| Total Cites | 33566 | 38449 |
| H-index | 80 | 84 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 813 | 842 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 3520 | 3873 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 25468 | 27945 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.38 |
| Self-Citation Percentage |
12.70%
|
|
Levine, Douglas A.
NYU Langone Health,
2020 Rank: 108205
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4390 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108205 | 118087 |
| Total Cites | 24472 | 28533 |
| H-index | 70 | 76 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 776 | 805 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 2792 | 3183 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18785 | 20864 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.37 |
| Self-Citation Percentage |
14.23%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.